In this study, our in vivo and in vitro results showed that EUG treatment down-regulated the expression of BAX and Cleaved Caspase-3, while up-regulated the level of BCL2 in the T1DM mice. The gene discussed is CASP3; the disease is type 1 diabetes mellitus.